Vertex Pharmaceuticals Incorporated data readout from a phase 3 program, using VX-548 for the treatment of patients with acute pain, could be released by the 1st half of 2024. Proof of concept, using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback